Acquisition, Discontinuation of Operations and Deconsolidation of Vitel and Oncbiomune Mexico - Schedule of Discontinued Operations Financial Statements (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
Cash
Total current assets
Total assets
Accounts payable	686,547	692,592
Due to related parties		432
Payroll liabilities		1,972
Total current liabilities	686,547	694,996
Total liabilities	686,547	694,996
Revenues		445,601
Cost of revenues		255,866
Gross (loss) profit		189,735
Compensation expense		335,381
Professional fees		171,043
Impairment loss - goodwill and other intangibles		4,760,646
General and administrative expenses		235,188
Total operating expenses		5,502,258
Loss from operations		(5,312,523)
Other expense, net		(16,107)
Loss from discontinued operations		(5,328,630)
Loss from disposal of discontinued operations - impairment of tangible assets		(335,472)
Loss from discontinued operations, net of income taxes		$ (5,664,102)